Home - Products - Microbiology/Virology - HBV - HBV-IN-37

HBV-IN-37

CAS No. 380483-01-2

HBV-IN-37( —— )

Catalog No. M37076 CAS No. 380483-01-2

HBV-IN-37 is an HBV inhibitor with an EC50 value of 10 μM and can be used for hepatitis B disease-related research.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
10MG	42	In Stock
25MG	70	In Stock
50MG	102	In Stock
100MG	152	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

HBV-IN-37
Note

Research use only, not for human use.
Brief Description

HBV-IN-37 is an HBV inhibitor with an EC50 value of 10 μM and can be used for hepatitis B disease-related research.
Description

HBV-IN-37 is an inhibitor of HBV with an EC50 value of 10 μM.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Microbiology/Virology
Target

HBV
Recptor

HBV
Research Area

——
Indication

——

Chemical Information

CAS Number

380483-01-2
Formula Weight

439.96
Molecular Formula

C23H22ClN3O2S
Purity

>98% (HPLC)
Solubility

——
SMILES

C(N1C(C=2C(=NN(C2)C3=CC=CC=C3)C4=CC=C(Cl)C=C4)SCC1=O)C5CCCO5
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

CD437

CD437 is a specifc Retinoic Acid Receptor γ (RARγ) agonist.
DVR-01

DVR-01 is an HBV capsid inhibitor and can be used in studies about the treatment of Hepatitis B virus (HBV) infection and related conditions.
Canocapavir

Canocapavir (ZM-H1505R) is a novel orally available HBV coat protein modulator with antiviral activity that induces conformational changes in the linker region of the HBV core protein, and can be used for the treatment of hepatitis B virus.

Sign In Join Free